- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13.12. | NICE recommends Santhera's Duchenne muscular dystrophy drug Agamree | ||
| 13.12. | Amar Urhekar announced as CEO of Avalere Health | ||
| 12.12. | AstraZeneca's Imfinzi granted FDA approval in limited-stage small cell lung cancer | ||
| 12.12. | Sanofi receives FDA fast track designation for COVID-19/flu combination vaccines | ||
| 11.12. | GSK gains exclusive option on DualityBio's preclinical ADC in deal worth over $1bn | ||
| 11.12. | Merck and Ridgeback initiate phase 3 study of COVID-19 oral antiviral in high-risk adults | ||
| 10.12. | J&J presents positive phase 3 results for Darzalex Faspro in smouldering multiple myeloma | ||
| 10.12. | Roche announces five-year results for Polivy combination in diffuse large B-cell lymphoma | ||
| 09.12. | Sanofi's rilzabrutinib shows promise in phase 3 immune thrombocytopenia study | ||
| 09.12. | Regeneron shares positive late-stage results for poze-cemdi in rare blood disorder PNH | ||
| 06.12. | Sanofi unveils plans to build €1bn insulin production base in China | ||
| 06.12. | Amgen announces $1bn investment to establish new US drug manufacturing facility | ||
| 05.12. | GSK and Rgenta to develop RNA-targeting small molecules in deal worth up to $500m per target | ||
| 05.12. | LEO Pharma's Anzupgo cream granted MHRA approval to treat chronic hand eczema | ||
| 05.12. | ICR study reveals how PARP inhibitor resistance develops in prostate cancer patients | ||
| 05.12. | AstraZeneca appoints Iskra Reic as executive vice president international | ||
| 04.12. | Ipsen enters $610m licensing deal with Biomunex to advance MAIT-cell engager | ||
| 04.12. | NICE recommends Immunocore's Kimmtrak as first drug for aggressive eye cancer | ||
| 04.12. | Best practices for conquering data management challenges in the pharma industry | ||
| 03.12. | Novartis gains rights to PTC's Huntington's programme in deal worth up to $2.9bn | ||
| 03.12. | Amgen's investigational weight-loss drug MariTide shows promise in mid-stage study | ||
| 03.12. | Bridging gaps and breaking barriers in pharma alliances | ||
| 02.12. | MHRA urges companies to prepare for Windsor Framework for medicines | ||
| 02.12. | Merck shares positive phase 3 results for pulmonary arterial hypertension therapy | ||
| 02.12. | Enabling a sustainable and mutually beneficial CDMO partnership |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
